It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
weather icon

23

SUNNY

TOKYO (8 p.m.)

TODAY'S PRINT EDITION

The Japan Times The Japan Times

Oxford University

  • Login
  • SUBSCRIBE
  • My Account
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
WHO approval of AstraZeneca-Oxford vaccine widens access in developing world

World Feb 16, 2021

WHO approval of AstraZeneca-Oxford vaccine widens access in developing world

The WHO's review found that the vaccine met the "must-have" criteria for safety and that its efficacy benefits outweighed its risks.

Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says

World / Science & Health Feb 7, 2021

Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says

British drugmaker AstraZeneca said on Saturday its vaccine developed with Oxford University appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial. The study from South Africa's University of the Witwatersrand ...

AstraZeneca and Pfizer vaccines to be combined in Oxford trial

World / Science & Health Feb 4, 2021

AstraZeneca and Pfizer vaccines to be combined in Oxford trial

The trial will allow researchers to see whether two shots of different vaccines produce better or worse results than two doses of the same product.

Astra-Oxford coronavirus vaccine gets its first clearance with U.K. approval

World / Science & Health Dec 30, 2020

Astra-Oxford coronavirus vaccine gets its first clearance with U.K. approval

by Suzi Ring

AstraZeneca PLC and the University of Oxford’s Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that will be key to mass immunizations.

How a British COVID-19 vaccine went from pole position to troubled start

World / Science & Health | FOCUS Dec 27, 2020

How a British COVID-19 vaccine went from pole position to troubled start

by Steve Stecklow, Andrew Macaskill, Ludwig Burger, Kate Kelland and Emilio Parodi

A review of records and interviews with scientists and industry figures gives a detailed account of what went wrong with the Oxford-AstraZeneca study.

Testing times: More work needed on AstraZeneca/Oxford vaccine trials

World / Science & Health Dec 9, 2020

Testing times: More work needed on AstraZeneca/Oxford vaccine trials

by Kate Kelland

A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.

Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccine

World / Science & Health Dec 4, 2020

Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccine

by Ludwig Burger, Kate Kelland and Abhirup Roy

The two partners have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine.

AstraZeneca considers extra global vaccine trial as questions mount

World / Science & Health Nov 27, 2020

AstraZeneca considers extra global vaccine trial as questions mount

Many low- and middle-income countries are relying on the firm, which has pledged to sell its vaccine at cost during the pandemic.

Decades of work, and half a dose of fortune, drove Oxford vaccine success

World / Science & Health | FOCUS Nov 24, 2020

Decades of work, and half a dose of fortune, drove Oxford vaccine success

by Alistair Smout, Kate Kelland and Ludwig Burger

The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.

Oxford COVID-19 vaccine trial results due this year but not there yet, trial chief says

World / Science & Health Nov 4, 2020

Oxford COVID-19 vaccine trial results due this year but not there yet, trial chief says

A vaccine that works is seen as a game-changer in the battle against the coronavirus, which has killed more than 1.2 million people worldwide.

Oxford COVID-19 vaccine prompts immune response in adults, AstraZeneca says

World / Science & Health Oct 27, 2020

Oxford COVID-19 vaccine prompts immune response in adults, AstraZeneca says

The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among older people, British drug maker AstraZeneca PLC said on Monday. A vaccine that works is seen as a ...

U.K. firms apologize for slavery links as Bank of England plans to remove pictures

World / Social Issues Jun 19, 2020

U.K. firms apologize for slavery links as Bank of England plans to remove pictures

Global protests sparked by the killing of George Floyd are pushing the U.K. to acknowledge past links to slavery and racism. The Bank of England apologized for the involvement of some of its former governors and directors in the slave trade and is reviewing its ...

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Biden vows to defend Taiwan as Kishida pledges unprecedented hike in defense spending
    Biden and Kishida shake hands as they attend a bilateral meeting at the State Guesthouse in Tokyo on Monday.
  • Seven arrive from U.S. for first test tours before Japan reopens to tourism
    People from the United States arrive for the first small-scale test tours in Japan since measures were imposed to control the spread of COVID-19, at Narita Airport near Tokyo on Tuesday.
  • Government clarity needed as Japan eyes border reopening for tourism
    Japan is believed to have lost ¥10.96 trillion in revenue in 2020 and more than ¥22 trillion since the pandemic began after closing its borders to tourists in response to COVID-19.
  • Japanese political parties agree on outline of bill to protect porn victims
    Major Japanese ruling and opposition parties have agreed on an outline of a planned bill to protect people who appear in pornographic videos against their will.
  • Biden launches Indo-Pacific Economic Framework with 13 nations including Japan
    U.S. President Joe Biden, Indian Prime Minister Narendra Modi and Prime Minister Fumio Kishida attend the Indo-Pacific Economic Framework for Prosperity launch event on Monday in Tokyo.
  • China's Gen Z has the power to make or break western brands

    Thumbnail image
  • U.N. envoy faces pressure on China trip over new Xinjiang leak

    Thumbnail image
  • Another mass shooting, another U.S. gun control debate

    Thumbnail image
  • Biden’s repeated Taiwan remarks could risk triggering the very conflict he seeks to avoid

    Thumbnail image
  • Russian official calls out war in a fiery exit

    Thumbnail image

PODCAST

  • DEEP DIVE

    When will Japan open to tourists?

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Study in Japan JT for Women JT Bookclub Japanese School Directory The Japan Times Jobs
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times